Clinical Trials Directory

Trials / Unknown

UnknownNCT02388607

Sustained Attention Abilities in Schizophrenia

Sustained Attention Abilities, Attentional Resources and Cognitive Control Mechanisms in Schizophrenia

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Schizophrenia is a psychiatric pathology, which concerns around 1% of adult population. It is characterized by clinical symptoms combining positive and negative symptoms and thinking disorganization. Schizophrenia is also characterized by cognitive deficits, likely to play an important part in adaptation of these patients in their every-day life, and to affect their clinical symptomatology. Among them, there are deficits in sustained attention which are associated with a difficulty for these patients to maintain efficiently their cognitive activity on a source of stimulation or task. This basic attentional process is fundamental for the efficiency of the overall of cognitive processes, and so for all behaviors directed on an aim. The question of whether or not patients with schizophrenia have difficulty sustaining attention is of high relevance, in the sense that it could undermine performance on nearly any task and so provide a compelling causal explanation of many other impairments observed in these patients. Yet it has not been conclusively answered in over four decades of research. Consequently, the main objective of the protocol is to evaluate sustained attention abilities in schizophrenic patients and to better understand the specific functioning of cognitive and neural mechanisms underlying these abilities (attentional resources and cognitive control mechanisms).

Conditions

Interventions

TypeNameDescription
OTHERmeasurementsperformance measurements

Timeline

Start date
2015-03-01
Primary completion
2023-03-01
Completion
2023-03-01
First posted
2015-03-17
Last updated
2021-09-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02388607. Inclusion in this directory is not an endorsement.